Results 271 to 280 of about 134,446 (292)

CD19 Deficiency

2012
openaire   +1 more source

ANTI-HUMAN CD19 ANTIBODIES

2021
ALLAN BARRETT, BOYLES JEFFREY STREETMAN, BUDELSKY ALISON LEE SIM, RUBTSOVA KIRA VLADIMIROVNA, ZHANG GUIFENG, NA SONGQING   +5 more
openaire   +2 more sources

Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis

Cell
Lingying Ye, Hongjuan Lu, Na Ta
exaly  

Role of CD19 signal transduction in B cell biology

Immunologic Research, 2002
Robert H Carter
exaly  

CD19 antibodies and their uses

2012
RAO-NAIK CHETANA, KING DAVID JOHN, LIU JIE, HUANG HAICHUN, PASSMORE DAVID B, BELL ALASDAIR FRASER, CARDARELLI JOSEPHINE M, PAN CHIN, THI DO TO UYEN, CHEN SHARLINE, TANAMACHI DAWN M   +10 more
openaire   +2 more sources

CD19 as an attractive target for antibody-based therapy

MAbs, 2012
exaly  

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Molecular Therapy, 2017
Tanya Siddiqi, Nancy L Bartlett, Armin Ghobadi   +2 more
exaly  

CD19 Molecule

2018
openaire   +1 more source

Elimination of CD19-positive lymphoid malignancies by CD19-car expressing NK cells

2020
KLINGEMANN HANS G, BOISSEL LAURENT H, SOON-SHIONG PATRICK   +2 more
openaire   +4 more sources

An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis

Cell
Kun Pang, Yanan Yue, Songying Ye
exaly